Highnoon Labs Partners with Beximco Pharmaceuticals for Distribution in Pakistan

Highnoon Laboratories Limited (HINOON), a pharmaceutical company based in Pakistan, has revealed a strategic alliance with Beximco Pharmaceuticals Limited, a prominent drug manufacturer in Bangladesh. This collaboration aims to distribute and market specialized pharmaceutical products within Pakistan.

The pharmaceutical firm, listed on the Pakistan Stock Exchange (PSX), communicated this development in an official notice on Tuesday.

“The company has forged a strategic partnership with Beximco Pharmaceuticals Limited, a leading pharmaceutical organization in Bangladesh equipped with cutting-edge manufacturing facilities, accredited by regulatory bodies in the USA, Australia, the European Union, Canada, and Brazil,” the notice stated.

HINOON disclosed that a memorandum of understanding (MoU) has been signed by both entities. The purpose is to work together on distributing and marketing specialized pharmaceutical products across Pakistan, with a primary focus on therapeutic areas with high prevalence, including respiratory illnesses, diabetes, and cardiovascular conditions.

Focus on Newer Therapies

“Through this collaboration, the company intends to introduce innovative therapies, dosage formats, and delivery mechanisms to enhance ease of use and improve clinical outcomes for patients, as well as broaden access to advanced medications.

This strategic alliance is expected to significantly contribute to the ongoing expansion of trade relations and economic cooperation between Pakistan and Bangladesh,” the notice further mentioned.

Beximco Pharmaceuticals Ltd. is an emerging entity in generic drugs, dedicated to offering affordable medicines. Their current strategy involves establishing a presence in various emerging and developed markets worldwide.

Highnoon Laboratories Limited was initially established in Pakistan as a private limited company in 1984 before converting to a public limited company in 1995.

The company’s core operations encompass the manufacturing, import, sale, and marketing of pharmaceutical products and related consumer goods.